Pilot of the Virtual Memory Attention and Problem Solving Skills Intervention for Persons With Multiple Sclerosis (MS)
Launched by UNIVERSITY OF TEXAS AT AUSTIN · Nov 25, 2024
Trial Information
Current as of July 25, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring a new way to help people with Multiple Sclerosis (MS) improve their memory, attention, and problem-solving skills using a virtual format. The program, called MAPSS-MS, has already shown positive results when done in person, and now researchers want to see if it works just as well online. The trial will look at how feasible it is to participate in this virtual program and whether it can help participants feel better mentally and emotionally compared to those who are not in the program.
To be eligible for this trial, participants need to be between 21 and 85 years old, have been diagnosed with MS for at least a year, and have access to a phone or computer with the internet. They should also have some cognitive challenges, as indicated by a questionnaire. Those who join will take part in eight online group sessions led by an expert, where they will learn strategies to manage common cognitive issues. Participants will also use a computer program called Brain HQ to practice brain games at home. They will complete surveys and cognitive tests before starting the program, right after it ends, and six weeks later to measure any improvements.
Gender
ALL
Eligibility criteria
- • Inclusion Criteria: Age 21 -85 years old, reside in the United States, MS diagnosis for at least 1 years, access and ability to use phone, computer and Internet, Score of ≥10 on the Perceived Deficits Questionnaire (PDQ), adequate vision and motor skills to use the computer for testing and to participate in the intervention.
- • Exclusion Criteria:A diagnosis of dementia/head injury, inability to speak English, severe functional limitation that makes use of computer for intervention and testing impossible; prior participation in a cognitive rehab intervention during the last year; currently using Brain HQ at home.
- • -
About University Of Texas At Austin
The University of Texas at Austin, a leading research institution, is dedicated to advancing knowledge and innovation in the field of healthcare through rigorous clinical trials. Known for its commitment to scientific excellence, the university leverages its diverse expertise and cutting-edge facilities to conduct research that addresses critical health challenges. Collaborating with a multidisciplinary team of researchers, clinicians, and students, the University of Texas at Austin aims to translate scientific discoveries into effective treatments and interventions, ultimately enhancing patient outcomes and contributing to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported